ALD-102 Solution — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10 (month) in 11d
ESTIMATED |
READOUT
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Prel
Phase 1/2 · Alopecia Areata (AA) |
Aldena Therapeutics | ALD-102 Solution |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|